Top Clinical Trials companies in France by Cash and Short-Term Investments
France
# |
Name |
Cash and Short-Term Investments |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 288.07 M
|
Dec. 31, 2023 | USD 5.91 | -2.66% |
|
France |
|
| 2 |
USD 141.37 M
|
Dec. 31, 2023 | USD 4.22 | -0.94% |
|
France |
|
| 3 |
USD 102.05 M
|
Dec. 31, 2023 | USD 2.01 | -0.78% |
|
France |
|
| 4 |
USD 85.86 M
|
Dec. 31, 2023 | USD 3.91 | 3.55% |
|
France |
|
| 5 |
USD 83.09 M
|
Dec. 31, 2023 | USD 3.47 | -1.52% |
|
France |
|
| 6 |
USD 56.06 M
|
Dec. 31, 2023 | USD 0.65 | 1.19% |
|
France |
|
| 7 |
USD 29.79 M
|
Dec. 31, 2023 | USD 2.43 | 0.68% |
|
France |
|
| 8 |
USD 27.61 M
|
Dec. 31, 2023 | USD 1.39 | 1.77% |
|
France |
|
| 9 |
USD 26.84 M
|
Dec. 31, 2023 | USD 7.66 | 0.25% |
|
France |
|
| 10 |
USD 22.33 M
|
Dec. 31, 2023 | USD 2.58 | -11.21% |
|
France |
|
| 11 |
USD 21.67 M
|
Dec. 31, 2023 | USD 3.55 | 2.04% |
|
France |
|
| 12 |
USD 21.00 M
|
March 31, 2024 | USD 16.83 | 1.50% |
|
France |
|
| 13 |
USD 20.61 M
|
Dec. 31, 2023 | USD 6.63 | -0.22% |
|
France |
|
| 14 |
USD 14.31 M
|
Dec. 31, 2023 | USD 5.64 | -2.27% |
|
France |
|
| 15 |
USD 9.53 M
|
Dec. 31, 2023 | USD 21.38 K | 0.34% |
|
France |
|
| 16 |
USD 6.70 M
|
Dec. 31, 2023 | USD 1.64 | 4.90% |
|
France |
|
| 17 |
USD 5.79 M
|
Dec. 31, 2023 | USD 2.06 | -0.75% |
|
France |
|
| 18 |
USD 3.78 M
|
Dec. 31, 2023 | USD 3.87 | -3.39% |
|
France |
|
| 19 |
USD 2.54 M
|
Dec. 31, 2023 | USD 2.03 | 3.98% |
|
France |
|
| 20 |
USD 1.83 M
|
Dec. 31, 2023 | USD 1.45 | 1.71% |
|
France |
Frequently Asked Questions
-
Which Clinical Trials company in France has the highest Cash and Short-Term Investments ?
The Clinical Trials company in France with the highest Cash and Short-Term Investments is ABIVAX SA (Paris Stock Exchange: ABVX.PA) at USD 288.07 M.
-
Which Clinical Trials company in France has the lowest Cash and Short-Term Investments ?
The Clinical Trials company in France with the lowest Cash and Short-Term Investments is Affluent Medical SA (Paris Stock Exchange: AFME.PA) at USD 1.83 M.
-
What are the top 10 Clinical Trials companies in France by Cash and Short-Term Investments ?
The top 10 Clinical Trials companies in France by Cash and Short-Term Investments are ABIVAX SA, DBV Technologies S.A., Innate Pharma S.A., Genfit S.A., Nanobiotix S.A., Novacyt S.A., Inventiva S.A., Valbiotis SA, MaaT Pharma SA and Aelis Farma SA.
-
What are the bottom 10 Clinical Trials companies in France by Cash and Short-Term Investments ?
The bottom 10 Clinical Trials companies in France by Cash and Short-Term Investments are Affluent Medical SA, Crossject SA, Predilife S.A., Advicenne S.A., AB Science S.A., Eurofins-Cerep SA, Adocia SA, OSE Immunotherapeutics SA, MedinCell S.A. and Median Technologies SA.
